Research on CBD’s benefits for human health shows it can help with various conditions like stress, anxiety, depression, and cardiovascular diseases. Similar findings are emerging in companion animals, suggesting CBD could benefit species already experiencing conditions like these. Aging pets may particularly benefit from CBD treatments, but due to limited long-term safety data, more research is needed in this area to fully understand its effects on animals.
There are concerns regarding the accuracy and contamination of CBD products in the marketplace. Hemp, a common ingredient in CBD products, is known to accumulate toxic elements from contaminated soil. Studies have found that a significant percentage of CBD products contain heavy metals, pesticides, and solvents, with lead being the most common contaminant. Additionally, many CBD products fail to accurately label their CBD content, which poses a risk not only for humans but also for pets, especially as pet owners may use human products to treat their animals. This highlights the need for stricter quality control and regulatory standards in the CBD market.
CBD products marketed for animals often lack clear and accurate labeling, making it difficult for consumers to know the exact content and dosage. While the FDA does not approve CBD for use in animals, some regions outside the US, such as the UK and EU, regulate CBD as a veterinary medicine, although these products are often sold as supplements. The lack of regulation and quality assurance in the current market poses risks to pet health. While research into CBD for companion animals shows promise, we need reliable, well-regulated products to ensure safety and efficacy. For pet owners and veterinarians to properly understand CBD’s potential benefits, more research is needed, especially for underrepresented species like cats.
Summary of
Rideout et al. Journal of Cannabis Research https//doi.org/10.1186/s42238-024-00257-5
CBD for pets: navigating quality assurance, safety standards, and marketing strategies